Good Sport....I'm not going to track this any further but this should answer your question as follows..........
At December 31, 2014 we had $7,642 cash on hand along with NeoGenomics Stock for sale worth $362,373. As a result, the Company estimates cash will be depleted by the fourth quarter of 2015 unless the Company is able to raise additional equity capital. See Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations for additional disclosure regarding our liquidity and capital resources.
Market Data 
Markets 
AI
